A new study provides the first estimates of the prevalence of antiphospholipid antibodies in patients suffering from pregnancy loss, stroke, myocardial infarction and deep vein thrombosis.
A new study provides the first estimates of the prevalence of antiphospholipid antibodies in patients suffering from pregnancy loss, stroke, myocardial infarction and deep vein thrombosis.